The synthesis of A- and B-ring fluorinated analogues of cholesterol

Abstract

The synthesis of a number of mono- and difluorinated steroids with the potential to act as probes of the metabolism of cholesterol is described. 2α-Fluorocholestan-3-one 7, 4-fluorocholest-5-en-3-one 11 and 6-fluorocholest-4-en-3-one 12 were synthesised from the appropriate silyl enol ethers using 1-fluoropyridinium triflate, and subsequently reduced to the corresponding alcohols, 8, 13 and 14 respectively. A similar approach was used to synthesise 2,2-difluorocholestan-3-ol 16 starting from the monofluoro steroid 7. To synthesise 4,4-difluorocholestan-3β-ol 26, 3β-acetoxycholestan-4-one 25 was generated via an acid catalysed rearrangement of 4,5-epoxycholestan-3-one 20 and treated with DAST. Finally, a difluorocyclopropyl analogue of cholesterol 28 was synthesised using chlorodifluoroacetic acid.

References

1. K. E. Suckling, Encyclopaedia Of Human Biology, Academic Press, London, 1997, vol. 1, pp. 555–563.
2. J. T. Welsh and S. Eswarakrishnan, Fluorine in Bioorganic Chemistry, John Wiley and Sons, New York, 1991; C. Walsh, Adv. Enzymol. Mol. Biol., 1983, 55, 197; D. O'Hagen and H. S. Rzepa, Chem. Commun., 1997, 645.
3. A. Bondi, J. Phys. Chem., 1964, 68, 441; M. Schlosser, Tetrahedron, 1996, 52, 99.
4. R. A. Harte, S. J. Yeaman, J. McElhinney, C. J. Suckling, B. Jackson and K. E. Suckling, Chem. Phys. Lipids, 1996, 83, 45; K. E. Suckling, B. Jackson, R. A. Suffolk, J. D. Houghton and C. J. Suckling, Biochim. Biophys. Acta, 1989, 1002, 401.
5. J. Twisk, M. F. M. Hoekman, L. M. Muller, T. Iida, T. Tamaru, A. Ijzerman, W. H. Mager and M. G. Princen, Eur. J. Biochem., 1995, 228, 596.
6. J. D. Houghton, S. E. Beddows and K. E. Suckling, Tetrahedron Lett., 1986, 27, 4655.
7. T. Umemoto, K. Kawada, K. Tomita, S. Fukami, G. Tomizowa and K. Harasawa, J. Am. Chem. Soc., 1990, 112, 8563.
8. A. L. Gemal and J.-L. Luche, J. Am. Chem. Soc., 1981, 103, 5454.
9. T. Nakaso, M. Makino, Y. Morizawa and Y. Matsumuru, Angew. Chem., Int. Ed. Engl., 1996, 35, 1019.
10. W. J. Middleton, J. Org. Chem., 1975, 40, 574.
11. D. J. Collins, J. Chem. Soc., 1959, 3919.
12. D. Lesuisse, J. F. Gourvest, C. Hartman, B. Tric, O. Benslimane, D. Philbert and J. P. Vevert, J. Med. Chem., 1992, 35, 1588.
13. J. F. Templeton, V. P. Sashi Kumar and R. K. Gupta, Steroids, 1986, 48, 339.
14. D. C. Wigeld, Tetrahedron, 1979, 35, 449.
15. J. M. Coxon, M. P. Hartshorn and D. N. Kirk, Tetrahedron, 1964, 20, 2547.
16. G. Sankar, G. P. Pez and R. G. Syvret, Chem. Rev., 1996, 96, 1737; E. Differding and G. M. Ruegg, Tetrahedron Lett., 1991, 32, 3815; E. Differding and M. Wehrli, Tetrahedron Lett., 1991, 32, 3819.
17. D. H. R. Barton, L. J. Danks, A. K. Ganguly, R. H. Hesse, G. Tarzia and M. M. Pechet, J. Chem. Soc., Chem. Commun., 1969, 227.
18. K. Suckling, C. J. Suckling, A. R. Pitt and M. G. Thomas, Drugs Associated with Lipid Metabolism, May 1998, Florence, Italy.
19. S. Nakanishi, K. Morita and E. V. Jensen, J. Am. Chem. Soc., 1959, 81, 5259.
20. H. B. Henbest and W. R. Jackson, J. Chem. Soc. C, 1967, 2269.
21. P. L. Julian, L. Bauer, C. L. Bell and R. E. Hewitson, J. Am. Chem. Soc., 1969, 91, 1690.